Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population

Clinical Respiratory Journal

Volumn 10, Issue 3, 2016, Pages 282-290

  Lill, Hille ^a   Kliiman, Kai ^a   Altraja, Alan ^a,b  

^a TARTU UNIVERSITY HOSPITAL   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

Clinical presentation; Extrapulmonary involvement; Gender difference; General complaints; Lung function; Sarcoidosis; Smoking habits

Indexed keywords

GLUCOCORTICOID; CARBON MONOXIDE;

ADULT; AGE; AIRWAY OBSTRUCTION; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ESTONIA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; OUTPATIENT DEPARTMENT; PATIENT CARE; PRIORITY JOURNAL; SARCOIDOSIS; SEX DIFFERENCE; SMOKING; SYMPTOM; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL; CHEMISTRY; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; SARCOIDOSIS, PULMONARY;

ADULT; CARBON MONOXIDE; ESTONIA; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SARCOIDOSIS, PULMONARY; SEX FACTORS;

EID: 84908409763     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12213     Document Type: Article

References (43)

1. Bauer HJ, Löfgren S. International study of pulmonary sarcoidosis in mass chest radiography. Acta Med Scand. 1964;176: 103-105.
2. Pietinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis. 1995;12(1): 61-67.
3. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis. 1990;7(1): 50-57.
4. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986;123(5): 840-845.
5. Hunninghake GW, Costabel U, Ando M, etal. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2): 149-173.
6. Sutherland I, Mitchell DN, Hart PD. Incidence of intrathoracic sarcoidosis among young adults participating in a trial of tuberculosis vaccines. Br Med J. 1965;2(5460): 497-503.
7. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130(1): 29-32.
8. Bresnitz EA, Stolley PD, Israel HL, Soper K. Possible risk factors for sarcoidosis. A case-control study. Ann N Y Acad Sci. 1986;465: 632-642.
9. Harf RA, Ethevenaux C, Gleize J, Perrin-Fayolle M, Guerin JC, Ollagnier C. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986;465: 625-631.
10. Valeyre D, Soler P, Clerici C, Pre J, Battesti JP, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43(7): 516-524.
11. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. Health-related quality of life of persons with sarcoidosis. Chest. 2004;125(3): 997-1004.
12. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med. 2007;175(1): 40-44.
13. Idali F, Wiken M, Wahlstrom J, Mellstedt H, Eklund A, Rabbani H, Grunewald J. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J. 2006;27(3): 451-459.
14. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2): 736-755.
15. Costabel U. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J. 1997;10(12): 2699-2700.
16. Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Muller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med. 2008;177(3): 330-336.
17. Miller MR, Hankinson J, Brusasco V, etal. Standardisation of spirometry. Eur Respir J. 2005;26(2): 319-338.
18. Macintyre N, Crapo RO, Viegi G, etal. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4): 720-735.
19. Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl. 1982;159: 5-20.
20. Viljanen AA, Viljanen BC, Halttunen PK, Kreus KE. Pulmonary diffusing capacity and volumes in healthy adults measured with the single breath technique. Scand J Clin Lab Invest Suppl. 1982;159: 21-34.
21. DeRemee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest. 1983;83(1): 128-133.
22. Sharma OP, Johnson R. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest. 1988;94(2): 343-346.
23. Harrison BD, Shaylor JM, Stokes TC, Wilkes AR. Airflow limitation in sarcoidosis - a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med. 1991;85(1): 59-64.
24. Stjernberg N, Thunell M. Pulmonary function in patients with endobronchial sarcoidosis. Acta Med Scand. 1984;215(2): 121-126.
25. Baughman RP, Teirstein AS, Judson MA, etal. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1): 1885-1889.
26. Benatar SR, Clark TJ. Pulmonary function in a case of endobronchial sarcoidosis. Am Rev Respir Dis. 1974;110(4): 490-496.
27. Chambellan A, Turbie P, Nunes H, Brauner M, Battesti JP, Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest. 2005;127(2): 472-481.
28. Radwan L, Grebska E, Koziorowski A. Small airways function in pulmonary sarcoidosis. Scand J Respir Dis. 1978;59(1): 37-43.
29. Carrington CB. Structure and function in sarcoidosis. Ann N Y Acad Sci. 1976;278: 265-283.
30. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest. 1995;107(2): 323-329.
31. Lynch JP III, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med. 1997;18(4): 755-785.
32. Bechtel JJ, Starr T III, Dantzker DR, Bower JS. Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis. 1981;124(6): 759-761.
33. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest. 2001;120(3): 881-886.
34. Sharma OP. Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis. 1993;147(6 Pt 1): 1598-1600.
35. Thelier N, Assous N, Job-Deslandre C, etal. Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments. J Rheumatol. 2008;35(8): 1622-1628.
36. Zisman DA, Shorr AF, Lynch JP III. Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med. 2002;23(6): 555-570.
37. Barnard J, Newman LS. Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol. 2001;13(1): 84-91.
38. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4): 735-737.
39. Anonymous. Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. J Clin Epidemiol. 1999;52(12): 1173-1186.
40. Judson MA, Thompson BW, Rabin DL, etal. The diagnostic pathway to sarcoidosis. Chest. 2003;123(2): 406-412.
41. Rizzato G, Palmieri G, Agrati AM, Zanussi C. The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(2): 119-126.
42. Parkes SA, Baker SB, Bourdillon RE, Murray CR, Rakshit M, Sarkies JW, Travers JP, Williams EW. Incidence of sarcoidosis in the Isle of Man. Thorax. 1985;40(4): 284-287.
43. Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration. 1994;61(4): 219-225.